Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.

Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.

Item
http://www.wikidata.org/entity/Q33339781
Targeted therapy in biliary tract cancers-current limitations and potentials in the future.Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trialsOutpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancerA phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract.Cytotoxic activity of Thai medicinal plants against human cholangiocarcinoma, laryngeal and hepatocarcinoma cells in vitro.A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.Guidelines for chemotherapy of biliary tract and ampullary carcinomasGRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS axis in hepatocellular carcinomaCholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma.TACC3 overexpression in cholangiocarcinoma correlates with poor prognosis and is a potential anti-cancer molecular drug target for HDAC inhibitorsAdvances in the management of biliary tract cancersDrug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines.Surgery and chemotherapy for intrahepatic cholangiocarcinoma.Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma.Synergistic Effect of Forbesione From Garcinia hanburyi in Combination with 5-Fluorouracil on Cholangiocarcinoma
P2860

Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.

Item
http://www.wikidata.org/entity/Q33339781
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Phase II trial of cisplatin, i ...... acil for biliary tract cancer.
@ast
Phase II trial of cisplatin, i ...... acil for biliary tract cancer.
@en
Phase II trial of cisplatin, i ...... acil for biliary tract cancer.
@nl
type
label
Phase II trial of cisplatin, i ...... acil for biliary tract cancer.
@ast
Phase II trial of cisplatin, i ...... acil for biliary tract cancer.
@en
Phase II trial of cisplatin, i ...... acil for biliary tract cancer.
@nl
prefLabel
Phase II trial of cisplatin, i ...... acil for biliary tract cancer.
@ast
Phase II trial of cisplatin, i ...... acil for biliary tract cancer.
@en
Phase II trial of cisplatin, i ...... acil for biliary tract cancer.
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P921
P1433
P1476
Phase II trial of cisplatin, i ...... racil for biliary tract cancer
@en
P2093
P304
P31
P407
P433
P478
P577
P698
P921